1. Corporate Officers - P
2. Prestrelski Steven

Insider Trading History of Prestrelski Steven

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Prestrelski Steven since 2019. This trader's CIK number is 1744027. At the time of last reporting, Prestrelski Steven was the Chief Scientific Officer of Xeris Biopharma Holdings, Inc.. (stock ticker symbol XERS). Also see all insider trading activities at Xeris Biopharma Holdings, Inc..

Note that in the past PRESTRELSKI STEVEN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Xeris Pharmaceuticals Inc (XERS) by Prestrelski Steven

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	XERS	0	$0	30,000	$158,030	0	$0
2020	XERS	0	$0	10,000	$54,990	0	$0
2019	XERS	0	$0	55,720	$680,290	15,720	$18,706

Yearly summary of insider trading at Xeris Biopharma Holdings, Inc. (XERS) by Prestrelski Steven

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	XERS	0	$0	11,228	$27,160	11,228	$7,747

Insider trading activities at 2 companies by Prestrelski Steven:

1. Xeris Pharmaceuticals Inc (XERS)

2. Xeris Biopharma Holdings, Inc. (XERS)

Table 1. Insider trading of Xeris Pharmaceuticals Inc (XERS) by Prestrelski Steven

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-04-12	XERS	Sale	10,000	4.07	40,730
2021-01-13	XERS	Sale	10,000	6.01	60,060
2021-01-11	XERS	Sale	10,000	5.72	57,240
2020-01-13	XERS	Sale	10,000	5.50	54,990
2019-07-11	XERS	Sale	10,000	12.37	123,690
2019-10-11	XERS	Sale	10,000	7.97	79,750
2019-01-14	XERS	Sale	7,700	17.20	132,463
2019-04-11	XERS	Sale	10,000	9.56	95,650
2019-01-11	XERS	Sale	2,300	.00	0
2018-12-24	XERS	Option Ex	15,720	1.19	18,706
2018-12-26	XERS	Sale	15,720	15.82	248,737

Table 2. Insider trading of Xeris Biopharma Holdings, Inc. (XERS) by Prestrelski Steven

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-02-22	XERS	Option Ex	11,228	.69	7,747
2022-02-22	XERS	Sale	11,228	2.42	27,160

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prestrelski Steven (Chief Scientific Officer of Xeris Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month